Baird Financial Group, Inc. - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 3.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baird Financial Group, Inc. ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$634,106
+34.0%
23,274
+6.6%
0.00%
+100.0%
Q1 2023$473,076
+136233.1%
21,841
+28.0%
0.00%0.0%
Q4 2022$347
-99.9%
17,068
+81.2%
0.00%0.0%
Q3 2022$241,000
-86.7%
9,417
-92.6%
0.00%
-85.7%
Q3 2019$1,807,000
+10.3%
127,828
-13.0%
0.01%
+16.7%
Q2 2019$1,638,000146,9360.01%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,712,176$123,147,0006.01%
TANAKA CAPITAL MANAGEMENT INC 74,139$1,048,0003.38%
S&T BANK/PA 625,078$8,859,0001.92%
Parallel Advisors, LLC 1,277,851$18,062,0001.55%
AJ WEALTH STRATEGIES, LLC 595,828$8,422,0001.11%
Matarin Capital Management, LLC 891,636$12,603,0000.95%
Capital Impact Advisors, LLC 162,544$2,370,0000.90%
AMI ASSET MANAGEMENT CORP 775,685$10,964,0000.57%
Birchview Capital, LP 50,000$707,0000.47%
Zebra Capital Management LLC 25,409$359,0000.39%
View complete list of CORCEPT THERAPEUTICS INC shareholders